To prove that miR-196a directly targets ANXA1 in breast cancer cells, a wild-type 3′-UTR construct of ANXA1 and mutant 3′-UTR of ANXA1 construct was used with co-transfection of miR-196a vectors. Here, ANXA1 is linked to breast cancer.